Maipu Medical: Announcement on Participating in the 2024 Online Group Reception Day for Investors of Listed Companies in Guangdong
Maipu Medical: Announcement on the cancellation of the pledge of some shares of the company\'s actual controller and controlling shareholder
Medprin Regenerative Medical Technologies: Investor relations activity record form, August 19, 2024.
Medprin Regenerative Medical Technologies: Summary of Half-Year Report in 2024.
Medprin Regenerative Medical Technologies: Half-year report for the year 2024.
Medprin Regenerative Medical Technologies: Huatai United Securities Co., Ltd.'s continuous supervision and follow-up report on the first half of 2024 for Guangzhou Mike Bio-Regenerative Medical Technology Co., Ltd.
Medprin Regenerative Medical Technologies: Summary Table of Non-Operating Funds Used and Other Related Fund Transactions for the First Half of 2024.
Medprin Regenerative Medical Technologies: Announcement on partial share pledges by the actual controllers and major shareholders of the company.
Medprin Regenerative Medical Technologies: Verification opinion of the listing of restricted shares of Guangzhou Maipep Regenerative Medical Technology Co., Ltd.'s initial public offering by Huatai United Securities Co., Ltd.
Medprin Regenerative Medical Technologies: Notice on the Listing of Partly Restricted Shares Prior to Initial Public Offering
Medprin Regenerative Medical Technologies: 2024 Interim Performance Forecast
Medprin Regenerative Medical Technologies: Announcement of Resolutions from the Third Session of the Third Board of Directors
Medprin Regenerative Medical Technologies: Independent financial advisor report on the first grant of Guangzhou Maple Resurrection Medical Technology Co., Ltd.'s 2024 Restricted Stock Incentive Plan, by Shanghai Xingongyihe Enterprise Management Consulting Co., Ltd.
Medprin Regenerative Medical Technologies: Announcement of the resolution of the first extraordinary Shareholders' Meeting in 2024.
Medprin Regenerative Medical Technologies: Self-inspection report on insider information of the 2024 Restricted Stock Incentive Plan and the buying and selling of company stocks by the first recipients of incentives.
Medprin Regenerative Medical Technologies: Guangzhou Maitai Regenerative Medical Technology Co., Ltd.'s restricted stock incentive plan for 2024.
Medprin Regenerative Medical Technologies: List of first-time incentive recipients for the 2024 restricted stock incentive plan (grant date).
Medprin Regenerative Medical Technologies: Announcement of Resolutions of the Third Meeting of the Third Supervisory Committee
Medprin Regenerative Medical Technologies: Announcement on the first grant of restricted stocks to the beneficiaries of the 2024 restricted stock incentive plan.
Medprin Regenerative Medical Technologies: Legal opinion of Zhong Lun (Guangzhou) Law Firm regarding the first grant of Guangzhou HBMEDICINE Technology Co., Ltd.'s 2024 restricted stock incentive plan.
No Data